Distribution of citrate and citrate infusion rate during donor plasmaphereses

Background: The purpose of this study was to describe the distribution of trisodium‐citrate 4% (TSC) anticoagulant (AC) between the product and the donors undergoing plasma donation. Subjects and Methods: Data of 32 regular donors of plasma initially collected for a study published in 2010 were re‐a...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical apheresis Vol. 31; no. 1; pp. 59 - 62
Main Authors Evers, Josef, Taborski, Uwe
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.02.2016
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: The purpose of this study was to describe the distribution of trisodium‐citrate 4% (TSC) anticoagulant (AC) between the product and the donors undergoing plasma donation. Subjects and Methods: Data of 32 regular donors of plasma initially collected for a study published in 2010 were re‐analyzed to determine the amount of citrate received by the donor and the citrate infusion rate (CIR) in mg/kg/min to the donor. Donor plasmaphereses (DP) were performed with the automated Haemonetics plasma collecting system 2 (PCS2). Plasma volume was programmed at 760 ml including AC. CIR was calculated from citrate received by the donors divided by the body weight over time. Results: 130 ± 12 ml TSC was used for 760 ml plasma. An average of 110 ml TSC or 84.6% of citrate load was in collected plasma and not given to the donor. From the difference of 20 ml or 514 mg citrate an average CIR of 0.16 mg/kg/min was calculated. Conclusion: The total amount of citrate received by the donor is minimal and the average CIR is below the critical level of 1 mg/kg/min. J. Clin. Apheresis 31:59–62, 2016. © 2015 Wiley Periodicals, Inc.
Bibliography:ArticleID:JCA21403
ark:/67375/WNG-ZPH43P3R-6
istex:B38C518CEE8509A451C86FF25846391DDC81795B
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0733-2459
1098-1101
1098-1101
DOI:10.1002/jca.21403